Multifunctional Bioactive Dual-Layered Nanofibrous Matrix for Effective Breast Cancer Therapy and Enhanced Wound Healing
- PMID: 40296483
- PMCID: PMC12332832
- DOI: 10.1002/smll.202500717
Multifunctional Bioactive Dual-Layered Nanofibrous Matrix for Effective Breast Cancer Therapy and Enhanced Wound Healing
Abstract
Surgical resection is the primary treatment for triple-negative breast cancer (TNBC). Post-operative complications, including tumor recurrence and bacterial infections, hinder complete remission and long-term recovery. To address these challenges, a multifunctional bioactive dual-layered nanofibrous matrix (MBDL-NanoMat) featuring adaptive shape control, excellent wound adherence, tunable drug release profiles, and superior biocompatibility for post-surgical applications is developed. The MBDL-NanoMat comprises a hydrophilic (HyPhil) layer and a hydrophobic (HyPhob) layer, offering distinct functionalities. The HyPhil layer, electrospun with gelatin and copper peroxide nanoparticles (Cu NPs), rapidly releases Cu NPs to induce anticancer effects through chemodynamic therapy (CDT), ferroptosis, and cuproptosis along with antibacterial action. Near-infrared laser irradiation enhances therapeutic efficacy through photothermal therapy (PTT). The HyPhob layer ensures prolonged therapeutic effects by releasing therapeutic molecules, such as rapamycin, enabling sustained chemotherapy (CT) and antibacterial activity. This synergistic therapeutic system integrates multiple mechanisms-CT, CDT, PTT, ferroptosis, and cuproptosis-suppressing tumor recurrence and accelerating wound healing. Preclinical results demonstrated enhanced angiogenesis, collagen deposition, and dermal regeneration without systemic safety. In short, the MBDL-NanoMat platform offers a unique advantage in post-surgical TNBC care by simultaneously targeting tumor recurrence and facilitating wound healing. Further investigation of this platform can significantly improve oncological and regenerative medicine strategies.
Keywords: bacteria‐infected wound treatment; chemodynamic therapy (CDT); dual‐layered nanofibrous matrix; ferroptosis and cuproptosis; multifunctional biomaterials; photothermal therapy (PTT); triple‐negative breast cancer (TNBC).
© 2025 The Author(s). Small published by Wiley‐VCH GmbH.
Conflict of interest statement
DECLARATION OF COMPETING INTEREST
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Redox homeostasis disruptors enhanced cuproptosis effect for synergistic photothermal/chemodynamic therapy.J Colloid Interface Sci. 2025 Jan 15;678(Pt A):1060-1074. doi: 10.1016/j.jcis.2024.08.234. Epub 2024 Aug 31. J Colloid Interface Sci. 2025. PMID: 39236435
-
A bismuth-based double-network hydrogel-mediated synergistic photothermal-chemodynamic therapy for accelerated wound healing.J Mater Chem B. 2024 May 22;12(20):4975-4987. doi: 10.1039/d4tb00121d. J Mater Chem B. 2024. PMID: 38687157
-
Design of multi-layer electrospun poly(ε-caprolactone)/chitosan nanofiber scaffolds loaded with tigecycline for controlled drug release and antibacterial wound healing.Int J Biol Macromol. 2025 Sep;322(Pt 4):146955. doi: 10.1016/j.ijbiomac.2025.146955. Epub 2025 Aug 18. Int J Biol Macromol. 2025. PMID: 40834956
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Multimodal Synergistic Strategies for Diabetic Wound Healing Using Glucose Oxidase Nanocomposites: Therapeutic Mechanisms and Nanomaterial Design.Int J Nanomedicine. 2025 May 2;20:5727-5762. doi: 10.2147/IJN.S515057. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40337147 Free PMC article.
References
-
- a) Almansour NM, Triple-negative breast cancer: A brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence, Front. mol. biosci. 2022, 9, 836417.; - PMC - PubMed
- b) Leon-Ferre RA, Goetz MP, Advances in systemic therapies for triple negative breast cancer, BMJ-BRIT MED J 2023, 381, e071674. - PubMed
-
- a) Donnely E, Griffin M, Butler PE, Breast reconstruction with a tissue engineering and regenerative medicine approach (Systematic Review), Ann. Biomed. Eng. 2020, 48, 9–25.; - PMC - PubMed
- b) Shi Y, Zhou M, Zhao S et al. , Janus amphiphilic nanofiber membranes synergistically drive antibacterial and anti-inflammatory strategies for skin wound healing, Mater. Des. 2023, 227, 111778.
-
- van der Eerden PA, Lohuis PJFM, Hart AAM, Mulder WC, Vuyk H, Secondary intention healing after excision of nonmelanoma skin cancer of the head and neck: statistical evaluation of prognostic values of wound characteristics and final cosmetic results, Plast. Reconstr. Surg. 2008, 122, 1747–1755. - PubMed
MeSH terms
Substances
Grants and funding
- RS-2024-00352515/National Research Foundation of Korea (NRF) grant funded by the Ministry of Science and ICT
- 2022R1A6C101A739/Korea Basic Science Institute (National Research Facilities and Equipment Center) grant funded by the Ministry of Education
- R21 NS132556/NS/NINDS NIH HHS/United States
- RM1 NS133003-01/NIH RM1
- OCRP/Congressionally Directed Medical Research Programs
- RM1 NS133003/NS/NINDS NIH HHS/United States
- AARG-NTF-21-847862/ALZ/Alzheimer's Association/United States
- RS-2018-NR031068/National Research Foundation of Korea (NRF) grant funded by the Ministry of Education
- OC220235P1/Congressionally Directed Medical Research Programs
- 2020R1C1C1003945/National Research Foundation of Korea (NRF) grant funded by the Ministry of Science and ICT
- R01 NS130836/NS/NINDS NIH HHS/United States
- COCR23PPR007/NJ Commission on Cancer Research
- R21 NS132556-01/NIH R21
- 1R01NS130836-01A1/NIH R01
LinkOut - more resources
Full Text Sources
Medical